-
Pathology 811 a Hashimoto Thyroiditis inflammation Thyroid Auto immune CTLA4 PTPN22 Painless
16:45 Revision
Part 2 https://www.youtube.com/watch?v=X425sIZhNDw
Note that Hashimoto is Painless Enlargement
Hashimoto Thyroiditis inflammation Thyroid Auto immune Lymphocytic CTLA4 PTPN22 Pathogenesis Etiology
#hashimoto #thyroiditis #thyroid
published: 03 Oct 2019
-
SLE-PTPN22 Lupus Study Recruiting Participants
SLE is an autoimmune disease capable of causing severe tissue damage in many organs. The cause of SLE is unknown, but recent research has identified infection-fighting proteins called interferons (or IFNs) which are made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites or tumor cells. IFNs allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors.
In this video, Dr. Erik Peterson from the University of Minnesota, describes the basis for his new study which will look at how PTPN22 (one lupus risk gene) affects the interferon-producing capacity of lupus patients.
See the recording of Dr. Peterson's webinar (recorded Tuesday, April 30, 2013) to learn more about...
published: 07 May 2013
-
From HLA to the human genome: 30 years of chasing genes for rheumatoid arthritis
Crafoord Laureate 2013 Peter K. Gregersen, The Feinstein Institute for Medical Research, Manhasset, NY, USA. Introduction by Lars Kärre. From: Crafoord Prize Lectures & Prize Symposium in Polyarthritis 2013: From genes and environment to pathogenetic mechanisms and treatment of autoimmune diseases, 2013-05-03.
published: 16 Nov 2022
-
CTLA4 and attenuation of T cell response
this video describes how CTLA4,PD1 and BTLA works to inhibit T cell response
published: 04 Mar 2020
-
Gene Music using Protein Sequence of PTPN22 "PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22 (LY"
Shop PTPN22 - https://www.redbubble.com/people/genemusic/works/53527294-ptpn22?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Gene Music Studio - A channel to taste (visually & musically) gene information (particularly protein sequences)
Gene Music using Protein Sequence of PTPN22 'PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22 (LYMPHOID)'
published: 11 Jan 2017
-
New Target for Pancreatic Cancer: Boosting Immunotherapy Effectiveness
Learn how Won Jin Ho, MD, Johns Hopkins University, 2023 Harrington Scholar-Innovator, is pioneering a treatment for pancreatic ductal cancer by inhibiting PTPN22 to enhance antitumor immunity. His work could revolutionize immunotherapy for pancreatic cancer and beyond. Harrington Discovery Institute at University Hospitals in Cleveland, Ohio aims to accelerate promising discoveries into medicines for unmet needs. Learn more: HarringtonDiscovery.org.
published: 28 Oct 2024
-
Battling Cancer with the Immune System
PTPN22 is a gene already used in the fight against Type 1 Diabetes and Rheumatoid Arthritis. Now, Scripps researchers are discovering how PTPN22 might be used to help cure cancer.
published: 04 Sep 2018
-
Association between polymorphisms in the INS, PTPN22 and CTLA-4 genes and type 1 diabetes mellitus
published: 08 Sep 2021
-
Y. Ge - Genetic risk factors shared by multiple distinct autoimmune diseases
Yan Ge, Principal Investigator, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre: Taizhou, Jiangsu Province, CHINA speaks on "enetic risk factors shared by multiple distinct autoimmune diseases".
Abstract
Autoimmune diseases are a group of related disorders where one’s immune system attacks and damages one’s own tissues. Both genetic and environmental factors contribute to autoimmune disease. Genome- wide association (GWAS) and fine-mapping studies have identified a large number of risk loci for common autoimmune diseases in humans. However, the disease-causal variants and genes still remain largely unknown, and little is known about the interplay and joint action of these genetic risk loci in autoimmune disease. To tackle these major challeng...
published: 07 Nov 2023
-
High Yielding Shorts-42 (#HYS-42) : Hashimoto’s thyroiditis by Dr. Devesh Mishra.
*******
This High Yielding Shorts (#HYS) is about introduction, gross and microscopic findings of Hashimoto’s thyroiditis.
*********
Dr Devesh Mishra, M.B.B.S., M.D. Pathology.
Owner and Founder of "DPMA" (Devesh Premier Medical Academy), and DEVAANSH publication.
A passionate National level faculty of PATHOLOGY and BIOLOGY.
Authored best selling PATHOLOGY book with title “Concepts In Pathology” under DEVAANSH publications.
Special interest in uplifting the positive mindset and lifestyle into everyone.
Special connections to learn more :-
1) DPMA Pathology lecture App website: https://dpma.co.in/
2) DEVAANSH Publications website : https://devaanshpublications.com/
3) Facebook page (DEVAANSH Publications): https://www.facebook.com/Devaansh-Publications-1616260661839147/
4) Telegram Gro...
published: 26 Jul 2021
20:00
Pathology 811 a Hashimoto Thyroiditis inflammation Thyroid Auto immune CTLA4 PTPN22 Painless
16:45 Revision
Part 2 https://www.youtube.com/watch?v=X425sIZhNDw
Note that Hashimoto is Painless Enlargement
Hashimoto Thyroiditis inflammation Thyroid Auto i...
16:45 Revision
Part 2 https://www.youtube.com/watch?v=X425sIZhNDw
Note that Hashimoto is Painless Enlargement
Hashimoto Thyroiditis inflammation Thyroid Auto immune Lymphocytic CTLA4 PTPN22 Pathogenesis Etiology
#hashimoto #thyroiditis #thyroid
https://wn.com/Pathology_811_A_Hashimoto_Thyroiditis_Inflammation_Thyroid_Auto_Immune_Ctla4_Ptpn22_Painless
16:45 Revision
Part 2 https://www.youtube.com/watch?v=X425sIZhNDw
Note that Hashimoto is Painless Enlargement
Hashimoto Thyroiditis inflammation Thyroid Auto immune Lymphocytic CTLA4 PTPN22 Pathogenesis Etiology
#hashimoto #thyroiditis #thyroid
- published: 03 Oct 2019
- views: 5415
3:20
SLE-PTPN22 Lupus Study Recruiting Participants
SLE is an autoimmune disease capable of causing severe tissue damage in many organs. The cause of SLE is unknown, but recent research has identified infection-f...
SLE is an autoimmune disease capable of causing severe tissue damage in many organs. The cause of SLE is unknown, but recent research has identified infection-fighting proteins called interferons (or IFNs) which are made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites or tumor cells. IFNs allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors.
In this video, Dr. Erik Peterson from the University of Minnesota, describes the basis for his new study which will look at how PTPN22 (one lupus risk gene) affects the interferon-producing capacity of lupus patients.
See the recording of Dr. Peterson's webinar (recorded Tuesday, April 30, 2013) to learn more about this research opportunity and find out how you can get involved:
https://wn.com/Sle_Ptpn22_Lupus_Study_Recruiting_Participants
SLE is an autoimmune disease capable of causing severe tissue damage in many organs. The cause of SLE is unknown, but recent research has identified infection-fighting proteins called interferons (or IFNs) which are made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites or tumor cells. IFNs allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors.
In this video, Dr. Erik Peterson from the University of Minnesota, describes the basis for his new study which will look at how PTPN22 (one lupus risk gene) affects the interferon-producing capacity of lupus patients.
See the recording of Dr. Peterson's webinar (recorded Tuesday, April 30, 2013) to learn more about this research opportunity and find out how you can get involved:
- published: 07 May 2013
- views: 602
43:25
From HLA to the human genome: 30 years of chasing genes for rheumatoid arthritis
Crafoord Laureate 2013 Peter K. Gregersen, The Feinstein Institute for Medical Research, Manhasset, NY, USA. Introduction by Lars Kärre. From: Crafoord Prize Le...
Crafoord Laureate 2013 Peter K. Gregersen, The Feinstein Institute for Medical Research, Manhasset, NY, USA. Introduction by Lars Kärre. From: Crafoord Prize Lectures & Prize Symposium in Polyarthritis 2013: From genes and environment to pathogenetic mechanisms and treatment of autoimmune diseases, 2013-05-03.
https://wn.com/From_Hla_To_The_Human_Genome_30_Years_Of_Chasing_Genes_For_Rheumatoid_Arthritis
Crafoord Laureate 2013 Peter K. Gregersen, The Feinstein Institute for Medical Research, Manhasset, NY, USA. Introduction by Lars Kärre. From: Crafoord Prize Lectures & Prize Symposium in Polyarthritis 2013: From genes and environment to pathogenetic mechanisms and treatment of autoimmune diseases, 2013-05-03.
- published: 16 Nov 2022
- views: 138
5:58
CTLA4 and attenuation of T cell response
this video describes how CTLA4,PD1 and BTLA works to inhibit T cell response
this video describes how CTLA4,PD1 and BTLA works to inhibit T cell response
https://wn.com/Ctla4_And_Attenuation_Of_T_Cell_Response
this video describes how CTLA4,PD1 and BTLA works to inhibit T cell response
- published: 04 Mar 2020
- views: 40024
1:43
Gene Music using Protein Sequence of PTPN22 "PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22 (LY"
Shop PTPN22 - https://www.redbubble.com/people/genemusic/works/53527294-ptpn22?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Ge...
Shop PTPN22 - https://www.redbubble.com/people/genemusic/works/53527294-ptpn22?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Gene Music Studio - A channel to taste (visually & musically) gene information (particularly protein sequences)
Gene Music using Protein Sequence of PTPN22 'PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22 (LYMPHOID)'
https://wn.com/Gene_Music_Using_Protein_Sequence_Of_Ptpn22_Protein_Tyrosine_Phosphatase,_Non_Receptor_Type_22_(Ly
Shop PTPN22 - https://www.redbubble.com/people/genemusic/works/53527294-ptpn22?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Gene Music Studio - A channel to taste (visually & musically) gene information (particularly protein sequences)
Gene Music using Protein Sequence of PTPN22 'PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22 (LYMPHOID)'
- published: 11 Jan 2017
- views: 196
2:41
New Target for Pancreatic Cancer: Boosting Immunotherapy Effectiveness
Learn how Won Jin Ho, MD, Johns Hopkins University, 2023 Harrington Scholar-Innovator, is pioneering a treatment for pancreatic ductal cancer by inhibiting PTPN...
Learn how Won Jin Ho, MD, Johns Hopkins University, 2023 Harrington Scholar-Innovator, is pioneering a treatment for pancreatic ductal cancer by inhibiting PTPN22 to enhance antitumor immunity. His work could revolutionize immunotherapy for pancreatic cancer and beyond. Harrington Discovery Institute at University Hospitals in Cleveland, Ohio aims to accelerate promising discoveries into medicines for unmet needs. Learn more: HarringtonDiscovery.org.
https://wn.com/New_Target_For_Pancreatic_Cancer_Boosting_Immunotherapy_Effectiveness
Learn how Won Jin Ho, MD, Johns Hopkins University, 2023 Harrington Scholar-Innovator, is pioneering a treatment for pancreatic ductal cancer by inhibiting PTPN22 to enhance antitumor immunity. His work could revolutionize immunotherapy for pancreatic cancer and beyond. Harrington Discovery Institute at University Hospitals in Cleveland, Ohio aims to accelerate promising discoveries into medicines for unmet needs. Learn more: HarringtonDiscovery.org.
- published: 28 Oct 2024
- views: 12
1:12
Battling Cancer with the Immune System
PTPN22 is a gene already used in the fight against Type 1 Diabetes and Rheumatoid Arthritis. Now, Scripps researchers are discovering how PTPN22 might be used t...
PTPN22 is a gene already used in the fight against Type 1 Diabetes and Rheumatoid Arthritis. Now, Scripps researchers are discovering how PTPN22 might be used to help cure cancer.
https://wn.com/Battling_Cancer_With_The_Immune_System
PTPN22 is a gene already used in the fight against Type 1 Diabetes and Rheumatoid Arthritis. Now, Scripps researchers are discovering how PTPN22 might be used to help cure cancer.
- published: 04 Sep 2018
- views: 233
42:21
Y. Ge - Genetic risk factors shared by multiple distinct autoimmune diseases
Yan Ge, Principal Investigator, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre: Taizhou, Jiangsu Province, CHINA ...
Yan Ge, Principal Investigator, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre: Taizhou, Jiangsu Province, CHINA speaks on "enetic risk factors shared by multiple distinct autoimmune diseases".
Abstract
Autoimmune diseases are a group of related disorders where one’s immune system attacks and damages one’s own tissues. Both genetic and environmental factors contribute to autoimmune disease. Genome- wide association (GWAS) and fine-mapping studies have identified a large number of risk loci for common autoimmune diseases in humans. However, the disease-causal variants and genes still remain largely unknown, and little is known about the interplay and joint action of these genetic risk loci in autoimmune disease. To tackle these major challenges and gain a holistic understanding of disease pathogenesis, we have investigated two independent risk loci that are shared by multiple distinct autoimmune diseases: UBASH3A and PTPN22. In this presentation, I will show our findings on (1) novel mechanisms of UBASH3A and its genetic variants in human T cells and autoimmunity, and (2) previously unknown interactions, both biochemical and statistical, between UBASH3A and PTPN22. These mechanistic insights have enabled us to develop new therapeutic strategies for autoimmune disease.
Biosketch
Dr. Yan Ge obtained her PhD and Master of Public Health degrees from the University of Virginia, USA. Since 2003, she has been studying the genetic and immunological causes of autoimmune disease. Her PhD thesis work uncovered new genetic determinants underlying clinical traits of systemic lupus erythematosus (a common autoimmune disease) in a mouse model. As a postdoc at the University of Florida (UF), USA, Dr. Ge identified novel genetic risk factors and molecular mechanisms underpinning autoimmunity and type 1 diabetes (another common autoimmune disease) in humans. In September 2022, she joined the ICGEB China Regional Research Centre as a Principal Investigator. Before joining ICGEB, she was an independent research faculty member at UF. Currently, Dr. Ge’s laboratory employs multidisciplinary approaches to elucidate the molecular networks underlying autoimmune response and specific clinical traits of autoimmune disease in humans, and leverages these new insights to develop better preventive and therapeutic strategies for autoimmune disease.
ORCID: https://orcid.org/0000-0003-2129-9438
https://wn.com/Y._Ge_Genetic_Risk_Factors_Shared_By_Multiple_Distinct_Autoimmune_Diseases
Yan Ge, Principal Investigator, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre: Taizhou, Jiangsu Province, CHINA speaks on "enetic risk factors shared by multiple distinct autoimmune diseases".
Abstract
Autoimmune diseases are a group of related disorders where one’s immune system attacks and damages one’s own tissues. Both genetic and environmental factors contribute to autoimmune disease. Genome- wide association (GWAS) and fine-mapping studies have identified a large number of risk loci for common autoimmune diseases in humans. However, the disease-causal variants and genes still remain largely unknown, and little is known about the interplay and joint action of these genetic risk loci in autoimmune disease. To tackle these major challenges and gain a holistic understanding of disease pathogenesis, we have investigated two independent risk loci that are shared by multiple distinct autoimmune diseases: UBASH3A and PTPN22. In this presentation, I will show our findings on (1) novel mechanisms of UBASH3A and its genetic variants in human T cells and autoimmunity, and (2) previously unknown interactions, both biochemical and statistical, between UBASH3A and PTPN22. These mechanistic insights have enabled us to develop new therapeutic strategies for autoimmune disease.
Biosketch
Dr. Yan Ge obtained her PhD and Master of Public Health degrees from the University of Virginia, USA. Since 2003, she has been studying the genetic and immunological causes of autoimmune disease. Her PhD thesis work uncovered new genetic determinants underlying clinical traits of systemic lupus erythematosus (a common autoimmune disease) in a mouse model. As a postdoc at the University of Florida (UF), USA, Dr. Ge identified novel genetic risk factors and molecular mechanisms underpinning autoimmunity and type 1 diabetes (another common autoimmune disease) in humans. In September 2022, she joined the ICGEB China Regional Research Centre as a Principal Investigator. Before joining ICGEB, she was an independent research faculty member at UF. Currently, Dr. Ge’s laboratory employs multidisciplinary approaches to elucidate the molecular networks underlying autoimmune response and specific clinical traits of autoimmune disease in humans, and leverages these new insights to develop better preventive and therapeutic strategies for autoimmune disease.
ORCID: https://orcid.org/0000-0003-2129-9438
- published: 07 Nov 2023
- views: 148
2:06
High Yielding Shorts-42 (#HYS-42) : Hashimoto’s thyroiditis by Dr. Devesh Mishra.
*******
This High Yielding Shorts (#HYS) is about introduction, gross and microscopic findings of Hashimoto’s thyroiditis.
*********
Dr Devesh Mishra, M.B.B...
*******
This High Yielding Shorts (#HYS) is about introduction, gross and microscopic findings of Hashimoto’s thyroiditis.
*********
Dr Devesh Mishra, M.B.B.S., M.D. Pathology.
Owner and Founder of "DPMA" (Devesh Premier Medical Academy), and DEVAANSH publication.
A passionate National level faculty of PATHOLOGY and BIOLOGY.
Authored best selling PATHOLOGY book with title “Concepts In Pathology” under DEVAANSH publications.
Special interest in uplifting the positive mindset and lifestyle into everyone.
Special connections to learn more :-
1) DPMA Pathology lecture App website: https://dpma.co.in/
2) DEVAANSH Publications website : https://devaanshpublications.com/
3) Facebook page (DEVAANSH Publications): https://www.facebook.com/Devaansh-Publications-1616260661839147/
4) Telegram Group (Pathology): https://t.me/DrDeveshMishra555
5) Telegram Channel: https://t.me/DrDeveshMishra55
6) Telegram (Biology) : https://t.me/drdeveshishraBiology
Best wishes to everyone.....
https://wn.com/High_Yielding_Shorts_42_(_Hys_42)_Hashimoto’S_Thyroiditis_By_Dr._Devesh_Mishra.
*******
This High Yielding Shorts (#HYS) is about introduction, gross and microscopic findings of Hashimoto’s thyroiditis.
*********
Dr Devesh Mishra, M.B.B.S., M.D. Pathology.
Owner and Founder of "DPMA" (Devesh Premier Medical Academy), and DEVAANSH publication.
A passionate National level faculty of PATHOLOGY and BIOLOGY.
Authored best selling PATHOLOGY book with title “Concepts In Pathology” under DEVAANSH publications.
Special interest in uplifting the positive mindset and lifestyle into everyone.
Special connections to learn more :-
1) DPMA Pathology lecture App website: https://dpma.co.in/
2) DEVAANSH Publications website : https://devaanshpublications.com/
3) Facebook page (DEVAANSH Publications): https://www.facebook.com/Devaansh-Publications-1616260661839147/
4) Telegram Group (Pathology): https://t.me/DrDeveshMishra555
5) Telegram Channel: https://t.me/DrDeveshMishra55
6) Telegram (Biology) : https://t.me/drdeveshishraBiology
Best wishes to everyone.....
- published: 26 Jul 2021
- views: 10641